PE Fund Investments
Torrent Pharma to buy Curatio Healthcare in Rs.2,100-Cr deal: report
Ahmedabad-based, publicly listed Torrent Pharmaceuticals is to acquire Curatio Healthcare, a Chennai-based manufacturer of skincare products, in a deal that will value Curatio at INR 2,100 crore. The transaction will see the exit of Curatio's investors including ChrysCapital (which holds a 20% stake) and Sequoia Capital India (33%). Edelweiss Financial Services and MAPE are the advisers for the transaction. Curatio posted revenue of INR 240 crore in FY22 with an operating profit of INR 60 crore. It operates through a network of more than 700 distributors, reaching to over 6,000 doctors across India, focusing on dermatologists, paediatricians and gynaecologists. Its top selling brands include the Tedibar baby soap.
From the Venture Intelligence PE-VC Deal Database: Between Sep-15 and Aug-20, Curatio had attracted over USD 35 M from ChrysCapital, Sequoia Capital India and Fulcrum PE. (Subscribers to the database can login to view the valuation, deal structuring and other transaction details.)
Want to receive such news items in your inbox? Click Here to sign up for a trial.
